How much do paid clinical trials in Gastonia pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Are clinical trials in Gastonia safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Gastonia, NC?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

What is the difference between a research center and a hospital study in Gastonia?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Gastonia typically complete one or two studies per year.

Paid Clinical Trials Gastonia, NC — 650 Studies Recruiting (Jul 2026)

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Renal Cell Carcinoma Phase 3 Interventional 904 participants sought

Carolina Oncology Specialists, PA ( Site 9002) — Charlotte, North Carolina (19.4 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT07227402)

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Phase 1 Interventional 36 participants sought

Atrium Health Levine Cancer Institute - Morehead — Charlotte, North Carolina (19.4 mi) · Sponsor: PeproMene Bio, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT05370430)

A Study of Dotinurad Versus Allopurinol in Participants With Gout

Gout Phase 3 Interventional 500 participants sought

DelRicht Research — Charlotte, North Carolina (19.4 mi) · Sponsor: Crystalys Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07089875)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension Phase 2 Interventional 280 participants sought

Retension Clinical Site — Charlotte, North Carolina (19.4 mi) · Sponsor: Retension Pharmaceuticals. Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07142356)

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

Narcolepsy Phase 2 Interventional 64 participants sought

Research Carolina Elite — Denver, North Carolina (21.4 mi) · Sponsor: Eisai Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07493265)

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

Knee Cartilage Defects Phase 3 Interventional 300 participants sought

Atrium Health Mercy — Charlotte, North Carolina (19.4 mi) · Sponsor: Medipost, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07339111)

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

Migraine Phase 3 Interventional 200 participants sought

OnSite Clinical Solutions — Charlotte, North Carolina (19.4 mi) · Sponsor: Pfizer

See eligibility & contact on ClinicalTrials.gov (NCT06616194)

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Aortoiliac Occlusive Disease N/A Observational 158 participants sought

Atrium Health Sanger Heart & Vascular Institute — Charlotte, North Carolina (19.4 mi) · Sponsor: W.L.Gore & Associates

See eligibility & contact on ClinicalTrials.gov (NCT06872905)

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

Pulmonary Disease, Chronic Obstructive Phase 3 Interventional 981 participants sought

GSK Investigational Site — Rock Hill, South Carolina (24.2 mi) · Sponsor: GlaxoSmithKline

See eligibility & contact on ClinicalTrials.gov (NCT06959095)

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Non-Muscle Invasive Bladder Neoplasms N/A Observational 150 participants sought

Urology Specialists of the Carolinas PLLC Charlotte — Charlotte, North Carolina (19.4 mi) · Sponsor: Janssen Research & Development, LLC

See eligibility & contact on ClinicalTrials.gov (NCT07309445)

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought

Research Site — Charlotte, North Carolina (19.4 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT07391657)

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Solid Tumor, Advanced Cancer Phase 1 Interventional 330 participants sought

Carolina BioOncology Institute — Huntersville, North Carolina (22.3 mi) · Sponsor: I-Mab Biopharma US Limited

See eligibility & contact on ClinicalTrials.gov (NCT04900818)

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

Active Rheumatoid Arthritis Phase 2 Interventional 180 participants sought

DJL Clinical Research PLLC (Network) cIRB — Charlotte, North Carolina (19.4 mi) · Sponsor: Elevara Medicines Limited

See eligibility & contact on ClinicalTrials.gov (NCT07409103)

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion N/A Interventional 126 participants sought

OrthoCarolina Research Institute, Inc — Charlotte, North Carolina (19.4 mi) · Sponsor: Kuros Biosurgery AG

See eligibility & contact on ClinicalTrials.gov (NCT07225751)

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Polymyositis, Dermatomyositis Phase 3 Interventional 240 participants sought

Research Site — Charlotte, North Carolina (19.4 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06455449)

A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

Recurrent or Metastatic Solid Tumors Phase 1 Interventional 76 participants sought

Research Site — Charlotte, North Carolina (19.4 mi) · Sponsor: Daiichi Sankyo

See eligibility & contact on ClinicalTrials.gov (NCT07015697)

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

Solid Tumors, Lymphoma Phase 2 Interventional 40 participants sought

Carolinas Medical Center/ Levine Children's Hospital — Charlotte, North Carolina (19.4 mi) · Sponsor: Spectrum Pharmaceuticals, Inc

See eligibility & contact on ClinicalTrials.gov (NCT04570423)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought

Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (19.4 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 3 Interventional 380 participants sought

Atrium Health Levine Cancer Institute /ID# 246199 — Charlotte, North Carolina (19.4 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT06158841)

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Phase 1 Interventional 80 participants sought

Carolina BioOncology — Huntersville, North Carolina (22.3 mi) · Sponsor: FBD Biologics Limited

See eligibility & contact on ClinicalTrials.gov (NCT05892718)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought

Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (19.4 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06672146)

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

Venous Thromboses, Venous Disease N/A Interventional 165 participants sought

Atrium Health-Sanger Heart and Vascular Institute — Charlotte, North Carolina (19.4 mi) · Sponsor: W.L.Gore & Associates

See eligibility & contact on ClinicalTrials.gov (NCT05489588)

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Breast Neoplasms Phase 3 Interventional 558 participants sought

Oncology Specialists of Charlotte Pa — Charlotte, North Carolina (19.4 mi) · Sponsor: BioNTech SE

See eligibility & contact on ClinicalTrials.gov (NCT07173751)

A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.

Malocclusion N/A Interventional 90 participants sought

J Chichetti PLLC 2 — Huntersville, North Carolina (22.3 mi) · Sponsor: Dentsply Sirona Implants and Consumables

See eligibility & contact on ClinicalTrials.gov (NCT07290790)

GORE® ENFORM Biomaterial Product Study

Hernia, Ventral, Hernia, Hiatal N/A Interventional 245 participants sought

Atrium Health — Charlotte, North Carolina (19.4 mi) · Sponsor: W.L.Gore & Associates

See eligibility & contact on ClinicalTrials.gov (NCT04718168)

Paid Clinical Trials in Gastonia, NC

Studies recruiting near Gastonia right now

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

A Study of Dotinurad Versus Allopurinol in Participants With Gout

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.

GORE® ENFORM Biomaterial Product Study

Top-rated research centers in Gastonia

Clinical Research of Gastonia

Atrium Health Levine Cancer Institute

Rose Research Center

DelRicht Research | Charlotte Clinical Trials

Queen City Clinical Research, PLLC

Catawba Research, LLC

New Hope Clinical Research, Inc.

Partners Health Management

Carolinas Research Center

Clinical trials in Gastonia: what's recruiting

How to enroll in a paid study in Gastonia

Frequently asked questions

Paid clinical trials near Gastonia

More of NC

New paid studies open every week